ArticleFrontiers in public health2026
How to promote orderly access to medical care: an empirical analysis based on the Chinese experience.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study focuses on the implementation of China's hierarchical diagnosis and treatment system, conducting an in-depth analysis from three dimensions-healthcare service framework, policy experimentation, and service utilization patterns-aiming to provide valuable insights for the construction and improvement of an orderly medical order in other countries of the world. Methods: Utilizing data from the Results: The analysis reveals notable shifts in healthcare-seeking patterns in China: regarding first-contact care, the proportion of urban/rural residents initiating care at primary healthcare institutions demonstrates overall contraction, while secondary hospitals show increased first-contact shares, and tertiary hospitals maintaining stable utilization around 8.0%. In outpatient services, primary institutions retain the highest annual visit volumes, yet tertiary hospitals exhibit the strongest average annual growth rate. Structural variation analysis shows both tiers are primary contributors to system-wide changes-primary institutions demonstrate pre-dominantly negative VSV (Value of Structural Variation) trends, contrasted by tertiary hospitals' consistently positive VSV. For inpatient care, tertiary hospitals display the most rapid service expansion, with sustained positive VSV since 2010 and structural contribution rates exceeding 35%. This trajectory has positioned tertiary institutions as the primary inpatient service providers. Conclusion: (1) China has established clear functional roles for different medical institutions across distinct tiers of care, thereby laying a solid foundation for orderly patient referrals; (2) The evolving distribution of healthcare services across different tiers of medical institutions in China suggests that gaps remain between the current patient referral patterns and the intended objectives of the hierarchical medical system, particularly for inpatient services; (3) China's policies to promote the hierarchical diagnosis and treatment system exhibit distinct regional characteristics, highlighting the need to further expand the implementation scope of these policies to promote the formation of an orderly healthcare-seeking pattern; (4) The role of tertiary hospitals in China's hierarchical diagnosis and treatment system requires further optimization; (5) Developing integrated healthcare delivery systems with vertically coordinated services and horizontally regulated competition among medical institutions at all levels should be a critical future direction for China's health system reform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.